Mycobacterial Cell Wall-DNA Complex (MCC) is formulated from Mycobacterium phlei, a non-pathogenic strain of mycobacteria. MCC has been shown to have immune stimulatory and apoptosis (programmed cell death) activity against... The product is a sterile biological composition in a sub-micron suspension.
- Mechanism
- Curator reviewed
MCC has a therapeutic potential in high grade transitional cell carcinomas of the bladder, including refractory CIS. The combination of MCC with hyaluronic acid (HA) enhances both the apoptosis-inducing activity of MCC against prostate cancer cell lines, and the immune stimulatory activity of MCC (stimulation of anticancer cytokine synthesis by human immune effector cells).
- Primary indication
- Bladder cancerCurator reviewed
Resolves to
What you can answer from here — as of April 02, 2025
Which drugs share a target with MCC, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account